Edward T Mathers - Net Worth and Insider Trading
Edward T Mathers Net Worth
The estimated net worth of Edward T Mathers is at least $218 Million dollars as of 2024-04-27. Edward T Mathers is the 10% Owner of Savara Inc and owns about 24,471,264 shares of Savara Inc (SVRA) stock worth over $108 Million. Edward T Mathers is the 10% Owner of Korro Bio Inc and owns about 1,090,793 shares of Korro Bio Inc (KRRO) stock worth over $69 Million. Edward T Mathers is also the 10% Owner of Monte Rosa Therapeutics Inc and owns about 7,692,298 shares of Monte Rosa Therapeutics Inc (GLUE) stock worth over $41 Million. Details can be seen in Edward T Mathers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Edward T Mathers has not made any transactions after 2024-04-22 and currently still holds the listed stock(s).
Transaction Summary of Edward T Mathers
Edward T Mathers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Edward T Mathers owns 15 companies in total, including Inozyme Pharma Inc (INZY) , Akouos Inc (AKUS) , and Rhythm Pharmaceuticals Inc (RYTM) among others .
Click here to see the complete history of Edward T Mathers’s form 4 insider trades.
Insider Ownership Summary of Edward T Mathers
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
INZY | Inozyme Pharma Inc | 2020-07-23 | director |
AKUS | Akouos Inc | 2020-06-25 | director |
RYTM | Rhythm Pharmaceuticals Inc | 2017-10-04 | director |
TRVI | Trevi Therapeutics Inc | 2019-05-07 | director |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-17 | director |
SYBX | Synlogic Inc | 2016-06-29 | director |
RARX | Ra Pharmaceuticals Inc | 2020-04-02 | director |
LQDA | Liquidia Corp | 2018-07-25 | director |
SVRA | Savara Inc | 2023-07-17 | 10 percent owner |
RPHM | Reneo Pharmaceuticals Inc | 2021-04-08 | director |
NEUE | NeueHealth Inc | 2021-06-24 | 10 percent owner |
GLUE | Monte Rosa Therapeutics Inc | 2021-06-28 | 10 percent owner |
SNTI | Senti Biosciences Inc | 2022-06-08 | director |
OBSEF | ObsEva SA | 2023-01-01 | director |
KRRO | Korro Bio Inc | 2024-04-22 | 10 percent owner |
Edward T Mathers Latest Holdings Summary
Edward T Mathers currently owns a total of 3 stocks. Among these stocks, Edward T Mathers owns 24,471,264 shares of Savara Inc (SVRA) as of July 17, 2023, with a value of $108 Million and a weighting of 49.6%. Edward T Mathers owns 1,090,793 shares of Korro Bio Inc (KRRO) as of April 22, 2024, with a value of $69 Million and a weighting of 31.55%. Edward T Mathers also owns 7,692,298 shares of Monte Rosa Therapeutics Inc (GLUE) as of June 28, 2021, with a value of $41 Million and a weighting of 18.85%.
Latest Holdings of Edward T Mathers
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SVRA | Savara Inc | 2023-07-17 | 24,471,264 | 4.41 | 107,918,274 |
KRRO | Korro Bio Inc | 2024-04-22 | 1,090,793 | 62.93 | 68,643,603 |
GLUE | Monte Rosa Therapeutics Inc | 2021-06-28 | 7,692,298 | 5.33 | 40,999,948 |
Holding Weightings of Edward T Mathers
Edward T Mathers Form 4 Trading Tracker
According to the SEC Form 4 filings, Edward T Mathers has made a total of 1 transactions in Savara Inc (SVRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Savara Inc is the acquisition of 333,333 shares on July 17, 2023, which cost Edward T Mathers around $999,999.
According to the SEC Form 4 filings, Edward T Mathers has made a total of 1 transactions in Korro Bio Inc (KRRO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Korro Bio Inc is the acquisition of 17,857 shares on April 22, 2024, which cost Edward T Mathers around $999,992.
According to the SEC Form 4 filings, Edward T Mathers has made a total of 1 transactions in Monte Rosa Therapeutics Inc (GLUE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Monte Rosa Therapeutics Inc is the acquisition of 1,050,000 shares on June 28, 2021, which cost Edward T Mathers around $20 Million.
Insider Trading History of Edward T Mathers
- 1
Edward T Mathers Trading Performance
GuruFocus tracks the stock performance after each of Edward T Mathers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Edward T Mathers is 17.71%. GuruFocus also compares Edward T Mathers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Edward T Mathers within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Edward T Mathers's insider trading performs compared to the benchmark.
Performance of Edward T Mathers
Average Return
-49.95%
Outperforming Transactions
0%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 14.92 | 17.71 | 22.87 | -49.95 | -39.93 | |
Relative Return to S&P 500(%) | 15.33 | 18.64 | 14.7 | -39.02 | -40.93 |
Edward T Mathers Ownership Network
Ownership Network List of Edward T Mathers
Ownership Network Relation of Edward T Mathers
Edward T Mathers Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Edward T Mathers is the director of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Edward T Mathers made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 7,523 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 7,523 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Edward T Mathers Mailing Address
Above is the net worth, insider trading, and ownership report for Edward T Mathers. You might contact Edward T Mathers via mailing address: C/o Medimmune, Inc., One Medimmune Way, Gaithersburg Md 20878.